知名代理咨询公司机构股东服务（ISS）最新报告显示，其已建议辉瑞投资者在年度股东大会上投票反对公司高管薪酬计划。

　　ISS机构认为，辉瑞CEO阿尔伯特·布尔拉（Albert Bourla）2024年总薪酬达3300万美元，与公司股价表现（全年下跌28%）及多项财务指标未达标存在“显著脱钩”。

　　该机构指出，辉瑞2024年营收同比下降42%（新冠产品需求锐减），但高管奖金池仍达基准目标的152%。

　　辉瑞董事会被指在非新冠业务转型目标中设置“过度宽松的调整项”，而股东回报低于行业均值，同期股息收益率仅3.2%。

　　辉瑞董事会辩护称，该薪酬方案“有效激励了非新冠业务的战略转型”，并强调布尔拉领导下的肿瘤学、基因治疗管线估值已增长190亿美元。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张俊 SF065

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.